Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
ziprasidone hydrochloride, Quantity: 43.44 mg (Equivalent: ziprasidone, Qty 40 mg)
Medis Pharma Pty Ltd
Ziprasidone hydrochloride
Capsule, hard
Excipient Ingredients: Gelatin; pregelatinised maize starch; magnesium stearate; indigo carmine; croscarmellose sodium; titanium dioxide; colloidal anhydrous silica
Oral
60
(S4) Prescription Only Medicine
for the treatment of schizophrenia, related psychoses, prevention of relapse and for maintenance of clinical improvement during continuation therapy;,as monotherapy for the short term treatment of acute manic or mixed episodes associated with bipolar I disorder.
Visual Identification: size 4 capsule: blue body, blue cap; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-03-05